Komori
Bml (4694) · PolicyRestated

Strict testing accuracy and quality-control systems

First written in FY2016. 9 of 10 entries say "Restated". Latest entry: FY2025.

10entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20252016: 120162017: 320172018: 320182019: 220192020: 020202021: 020212022: 020222023: 020232024: 020242025: 12025
Same theme, other companies
Clinical Laboratory Testing Quality Control and Quality Assurance FrameworkA theme 3 companies write about · 0 as a headwind · 3 as a tailwind

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「We will continue to improve customer satisfaction by obtaining ISO 9001 and ISO 15189, a management system specifically designed for clinical laboratories, and working to improve quality.」

    Continues the policy of improving quality and customer satisfaction based on ISO 9001 and ISO 15189.
  2. FY2019RestatedAnnual report

    「We will continue to improve customer satisfaction by obtaining ISO 9001 and ISO 15189, a management system specifically designed for clinical laboratories, and working to improve quality.」

    Continues the policy of improving testing quality and customer satisfaction based on ISO 9001 and ISO 15189.
  3. FY2019-Q3RestatedAnnual report

    「Fiscal 2018 was the first year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). We have continued the group vision established under the Sixth Medium-Term Management Plan, “To become a company trusted and chosen by the medical community,” and continue to work to improve quality and services.」

    Continues to improve quality and services in the first year of the Seventh Medium-Term Management Plan.
  4. FY2019-Q2RestatedAnnual report

    「Fiscal 2018 was the first year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). We have continued the group vision established under the Sixth Medium-Term Management Plan, “To become a company trusted and chosen by the medical community,” and continue to work to improve quality and services.」

    In the first year of the Seventh Medium-Term Management Plan, continues the previous group vision and works to improve quality and services.
  5. FY2019-Q1RestatedAnnual report

    「Fiscal 2018 was the first year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). We have continued the group vision established under the Sixth Medium-Term Management Plan, “To become a company trusted and chosen by the medical community,” and continue to work to improve quality and services.」

    Continues to improve quality and services in the first year of the new medium-term management plan.
  6. FY2018-Q3RestatedAnnual report

    「For us, fiscal 2017 was the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). We continue to work to improve quality and services in order to achieve our vision of becoming a company trusted and chosen by the medical community.」

    Continues to improve quality and services in the final year of the Sixth Medium-Term Management Plan.
  7. FY2018-Q2RestatedAnnual report

    「For us, fiscal 2017 was the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). We continue to work to improve quality and services in order to achieve our vision of becoming a company trusted and chosen by the medical community.」

    Indicates a continuing policy of improving quality and services.
  8. FY2018-Q1RestatedAnnual report

    「For us, fiscal 2017 was the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). We continue to work to improve quality and services in order to achieve our vision of becoming a company trusted and chosen by the medical community.」

    Although ISO certification itself is not mentioned, indicates a continuing policy of improving quality and services.
  9. FY2017RestatedAnnual report

    「We will continue to improve customer satisfaction by obtaining ISO 9001 and ISO 15189, a management system specifically designed for clinical laboratories, and working to improve quality.」

    Continues the policy of improving quality and customer satisfaction after obtaining ISO 9001 and ISO 15189 certification.
  10. FY2016First statedAnnual report

    「As an accredited facility of the College of American Pathologists (CAP), we operate a proficiency-testing program and have established strict quality-control systems after obtaining ISO 15189 accreditation.」

    Demonstrates a commitment to quality control based on CAP accreditation and ISO 15189 accreditation.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Bml's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.